Targeted drug for leukemia tested at Penn Medicine helps patients live longer
Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor drug that targets a specific...
Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor drug that targets a specific...
MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer Center A study at The...
Obstructive sleep apnea and short sleep duration have distinct clinical impacts; clinicians should avoid a 'one-size-fits-all' approach through proper diagnosis to prevent and treat sleep...
Circulation Journal Report DALLAS, April 1, 2019 -- A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander CPR nearly doubled; compression-only (or...
Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a...
FAIR Health market indices and trending reports once again bring valuable visibility into patient migratory patterns and healthcare costs NEW YORK, NY--April 1, 2019--From 2016...
Credit: © 2019 AANS CHARLOTTESVILLE, VA (APRIL 1, 2019). The April issue of Neurosurgical Focus (thejns.org/toc/foc/46/4) contains 15 new articles on the principles of enhanced...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.